EE200100559A - Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormis - Google Patents
Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormisInfo
- Publication number
- EE200100559A EE200100559A EEP200100559A EEP200100559A EE200100559A EE 200100559 A EE200100559 A EE 200100559A EE P200100559 A EEP200100559 A EE P200100559A EE P200100559 A EEP200100559 A EE P200100559A EE 200100559 A EE200100559 A EE 200100559A
- Authority
- EE
- Estonia
- Prior art keywords
- pharmaceutical composition
- dosage form
- unit dosage
- hydrogen sulfate
- acetylsalicylic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905497A FR2792836B3 (fr) | 1999-04-30 | 1999-04-30 | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
PCT/FR2000/001086 WO2000066130A1 (fr) | 1999-04-30 | 2000-04-25 | Composition pharmaceutique sous forme unitaire contenant de l'acide acetylsalicylique et de l'hydrogenosulfate de clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200100559A true EE200100559A (et) | 2003-02-17 |
Family
ID=9545071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100559A EE200100559A (et) | 1999-04-30 | 2000-04-25 | Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormis |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1178809A1 (xx) |
JP (1) | JP2002543137A (xx) |
KR (1) | KR20020005735A (xx) |
CN (1) | CN1359294A (xx) |
AR (1) | AR023789A1 (xx) |
AU (1) | AU4303600A (xx) |
BR (1) | BR0010194A (xx) |
CA (1) | CA2371231A1 (xx) |
CZ (1) | CZ20013887A3 (xx) |
EA (1) | EA200100959A1 (xx) |
EE (1) | EE200100559A (xx) |
FR (1) | FR2792836B3 (xx) |
HK (1) | HK1041823A1 (xx) |
HU (1) | HUP0202329A2 (xx) |
IL (1) | IL145648A0 (xx) |
IS (1) | IS6084A (xx) |
MX (1) | MXPA01011071A (xx) |
NO (1) | NO20015295L (xx) |
NZ (1) | NZ514248A (xx) |
PL (1) | PL351923A1 (xx) |
SK (1) | SK15542001A3 (xx) |
TR (1) | TR200103039T2 (xx) |
UY (1) | UY26131A1 (xx) |
WO (1) | WO2000066130A1 (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60135780D1 (de) | 2000-12-25 | 2008-10-23 | Daiichi Sankyo Co Ltd | Aspirin enthaltende medizinische zusammensetzungen |
US6767913B2 (en) | 2001-12-18 | 2004-07-27 | Teva Pharmaceutical Industries Ltd. | Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms |
US7074928B2 (en) | 2002-01-11 | 2006-07-11 | Teva Pharmaceutical Industries, Ltd. | Polymorphs of clopidogrel hydrogensulfate |
US6800759B2 (en) | 2002-08-02 | 2004-10-05 | Teva Pharmaceutical Industries Ltd. | Racemization and enantiomer separation of clopidogrel |
IL166593A0 (en) | 2002-08-02 | 2006-01-15 | Racemization and enantiomer separation of clopidogrel | |
JP4917255B2 (ja) * | 2003-10-16 | 2012-04-18 | 第一三共ヘルスケア株式会社 | サリチル酸類含有経口組成物 |
WO2005070464A2 (en) * | 2004-01-21 | 2005-08-04 | Biofarma Ilac Sanayi Ve Ticaret A.S. | A tablet formulation of clopidogrel bisulphate |
JP2008543843A (ja) * | 2005-06-13 | 2008-12-04 | エラン ファーマ インターナショナル リミテッド | ナノ粒子クロピドグレル及びアスピリンの配合製剤 |
KR20070009851A (ko) * | 2005-07-14 | 2007-01-19 | 씨제이 주식회사 | 클로피도그렐 황산수소염 함유 약학 조성물 |
KR100736024B1 (ko) * | 2005-09-21 | 2007-07-06 | 주식회사종근당 | 신규한 클로피도그렐 우선성 광학이성체의 이온교환수지착체와 그 제조방법 |
KR20070044323A (ko) * | 2005-10-24 | 2007-04-27 | 에스케이케미칼주식회사 | 보관안정성이 개선된 클로피도그렐 황산수소염 함유 경구용제제 |
US20100145053A1 (en) * | 2006-04-05 | 2010-06-10 | Cadila Healthcare Limited | Modified release clopidogrel formulation |
EP1900358A1 (en) * | 2006-09-16 | 2008-03-19 | Cimex Pharma AG | Pharmaceutical formulations comprising clopidogrel |
HUP0600839A3 (en) * | 2006-11-14 | 2008-09-29 | Egis Gyogyszergyar Nyrt | Solid pharmaceutical composition containing polymorph i of clopidogrel hydrogensulfate and process for the preparation thereof |
EP2255797A4 (en) * | 2008-02-22 | 2011-09-07 | Hanall Biopharma Co Ltd | COMPOSITE PREPARATION |
CN101695496A (zh) * | 2009-10-15 | 2010-04-21 | 苏春华 | 一种含有三氟柳和氯吡格雷的药物组合物 |
JP2013032289A (ja) * | 2009-10-28 | 2013-02-14 | Daiichi Sankyo Co Ltd | ワックス安定製剤 |
RU2484820C2 (ru) * | 2011-02-24 | 2013-06-20 | Общество с ограниченной ответственностью "Озон" | Комбинированное лекарственное средство, являющееся ингибитором агрегации тромбоцитов |
KR101675501B1 (ko) | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
CN102406938A (zh) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | 一种抗血栓的药物组合物 |
JP6004524B2 (ja) * | 2012-07-11 | 2016-10-12 | 大原薬品工業株式会社 | クロピドグレル硫酸塩含有錠剤の製造方法 |
JP5905165B2 (ja) * | 2013-08-02 | 2016-04-20 | サノフイ | アセチルサリチル酸およびクロピドグレルを含む医薬錠剤 |
CN104434932B (zh) * | 2014-12-18 | 2017-05-24 | 成都苑东生物制药股份有限公司 | 一种硫酸氢氯吡格雷阿司匹林片药物组合物及其制备方法 |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
CN115737578A (zh) * | 2022-11-23 | 2023-03-07 | 石家庄四药有限公司 | 一种硫酸氢氯吡格雷阿司匹林复方片及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623810B2 (fr) | 1987-02-17 | 1992-01-24 | Sanofi Sa | Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant |
US5576328A (en) * | 1994-01-31 | 1996-11-19 | Elf Sanofi | Method for the secondary prevention of ischemic events |
FR2744918B1 (fr) | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
-
1999
- 1999-04-30 FR FR9905497A patent/FR2792836B3/fr not_active Expired - Fee Related
-
2000
- 2000-04-25 MX MXPA01011071A patent/MXPA01011071A/es unknown
- 2000-04-25 EE EEP200100559A patent/EE200100559A/xx unknown
- 2000-04-25 CA CA002371231A patent/CA2371231A1/en not_active Abandoned
- 2000-04-25 NZ NZ514248A patent/NZ514248A/xx unknown
- 2000-04-25 IL IL14564800A patent/IL145648A0/xx unknown
- 2000-04-25 SK SK1554-2001A patent/SK15542001A3/sk unknown
- 2000-04-25 EP EP00922737A patent/EP1178809A1/fr not_active Withdrawn
- 2000-04-25 CZ CZ20013887A patent/CZ20013887A3/cs unknown
- 2000-04-25 HU HU0202329A patent/HUP0202329A2/hu unknown
- 2000-04-25 BR BR0010194-0A patent/BR0010194A/pt not_active Application Discontinuation
- 2000-04-25 JP JP2000615014A patent/JP2002543137A/ja not_active Withdrawn
- 2000-04-25 CN CN00807001A patent/CN1359294A/zh active Pending
- 2000-04-25 AU AU43036/00A patent/AU4303600A/en not_active Abandoned
- 2000-04-25 TR TR2001/03039T patent/TR200103039T2/xx unknown
- 2000-04-25 KR KR1020017013830A patent/KR20020005735A/ko not_active Application Discontinuation
- 2000-04-25 WO PCT/FR2000/001086 patent/WO2000066130A1/fr not_active Application Discontinuation
- 2000-04-25 EA EA200100959A patent/EA200100959A1/ru unknown
- 2000-04-25 PL PL00351923A patent/PL351923A1/xx not_active Application Discontinuation
- 2000-04-28 AR ARP000102020A patent/AR023789A1/es unknown
- 2000-04-28 UY UY26131A patent/UY26131A1/es not_active Application Discontinuation
-
2001
- 2001-09-25 IS IS6084A patent/IS6084A/is unknown
- 2001-10-29 NO NO20015295A patent/NO20015295L/no not_active Application Discontinuation
-
2002
- 2002-05-14 HK HK02103639.9A patent/HK1041823A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1178809A1 (fr) | 2002-02-13 |
TR200103039T2 (tr) | 2002-01-21 |
CA2371231A1 (en) | 2000-11-09 |
HK1041823A1 (zh) | 2002-07-26 |
EA200100959A1 (ru) | 2002-06-27 |
SK15542001A3 (sk) | 2002-02-05 |
NO20015295L (no) | 2001-12-21 |
MXPA01011071A (es) | 2002-07-22 |
AR023789A1 (es) | 2002-09-04 |
NZ514248A (en) | 2003-06-30 |
UY26131A1 (es) | 2000-12-29 |
AU4303600A (en) | 2000-11-17 |
IS6084A (is) | 2001-09-25 |
FR2792836B3 (fr) | 2001-07-27 |
BR0010194A (pt) | 2002-02-13 |
NO20015295D0 (no) | 2001-10-29 |
HUP0202329A2 (en) | 2002-10-28 |
PL351923A1 (en) | 2003-06-30 |
CN1359294A (zh) | 2002-07-17 |
WO2000066130A1 (fr) | 2000-11-09 |
CZ20013887A3 (cs) | 2002-02-13 |
FR2792836A1 (fr) | 2000-11-03 |
IL145648A0 (en) | 2002-06-30 |
JP2002543137A (ja) | 2002-12-17 |
KR20020005735A (ko) | 2002-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200100559A (et) | Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormis | |
HUP0302550A3 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines and pharmaceutical compositions containing them | |
HUP0203588A3 (en) | Analgesic pharmaceutical compositions and their use | |
EE04965B1 (et) | Imidasoimidasoolid ja triasoolid kui p?letikuvastased hendid, nende kasutamine ravimite valmistamiseks ning farmatseutiline kompositsioon | |
EE200300145A (et) | Asa- ja polüasanaftalenüülkarboksamiidid ja farmatseutiline kompositsioon | |
AP2003002726A0 (en) | Azabicyclic compounds preparation thereof and use as medicines in particular as antibacterial agents | |
NO20020464D0 (no) | Flerkomponent-farmasöytisk doseringsform | |
IS6304A (is) | Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau | |
HUP0203939A3 (en) | Pharmaceutical compounds and compositions containing them and their use | |
HUP0204071A3 (en) | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same and their use | |
DE60037816D1 (de) | Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka | |
HUP0300709A3 (en) | Pharmaceutical composition comprising pemetrexed together with monothiaglycerol l-cystein or thioglycolic acid | |
DE60322454D1 (de) | Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung | |
HUP0203121A3 (en) | Pharmaceutical composition containing substituted benzimidazoles and its use | |
PT1225902E (pt) | Composicao farmaceutica contendo ciclesonide para aplicacao na mucosa | |
DE69708130T2 (de) | A-oxo-butansäuren enthaltende pharmazeutische zusammensetzung | |
ATE290543T1 (de) | Pharmazeutische zusammensetzungen mit oligosacchariden und deren herstellung | |
EE05317B1 (et) | Etinlstradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina | |
ID29494A (id) | Pengatasan dalam atau kaitannya terhadap pengurangan bau | |
HUP0301348A3 (en) | Analgesic and anti-inflammatory compositions containing gox-2 inhibitors and their use | |
NO20013117D0 (no) | Kosmetisk preparat av spray-type og matriks anvendt i preparatet for dermal administrering | |
HUP0203383A3 (en) | Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof | |
AU1026399A (en) | Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy | |
EE200100607A (et) | Farmatseutiline kompositsioon granulaadi kujul jaselle valmistamismeetod | |
PL343988A1 (en) | Pharmacological composition containing active substances in the form of their solution |